From GlobeNewswire: 2024-11-19 09:00:00

The Cell Freezing Media Market was valued at USD 152.14 Billion in 2023, projected to reach USD 333.29 Billion by 2032, with a CAGR of 9.15%. Demand is driven by cell-based therapies, regenerative medicine, and biopharmaceutical research, with a focus on advanced cryopreservation solutions and safer cryoprotectants.

The importance of cell freezing media is highlighted in stem cell research, cancer treatment, and vaccine development, with a significant impact on cancer therapy advancements and U.S. oncology spending projected to reach USD 99 billion in 2023. The market growth is driven by the need for effective cryopreservation in modern medicine and personalized treatments.

Key players in the market include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, and BioLife Solutions, among others, offering a range of freezing media solutions to support drug development and personalized medicine. The market report covers segments by product, application, and end-use, focusing on the rising demand for cell-based therapies and advanced cryopreservation technologies.

Pharmaceutical and biotechnological companies dominate the market, accounting for 45% of revenue, with a focus on product development and maintaining cell integrity. Research and academic institutions are projected to grow at a CAGR of 9.91%, driven by increased funding in biotechnology research and clinical trials, emphasizing the need for advanced cryopreservation technologies.

Stem cell lines lead the market with a 59% revenue share in 2023 and are projected to grow at a CAGR of 9.73%, driven by regenerative medicine advances and clinical applications. DMSO maintains dominance with a 56% market share in 2023, expected to grow at a CAGR of 9.85%, due to its efficiency in preserving various cell types, including stem cells and immune cells.

North America currently leads the market with a 40% revenue share in 2023, driven by a strong biotech sector and demand for cell-based therapies. Asia Pacific is set for rapid growth in the cell freezing media market, driven by advancements in regenerative medicine and increasing clinical trials in the region. The Cell Freezing Media Market in North America is expected to continue growing due to advancements in biotechnology and government investments in healthcare infrastructure. The Asia Pacific region is projected to have the fastest growth rate, with a CAGR of 11.03% from 2024 to 2032, driven by initiatives in regenerative medicine and stem cell research, especially in countries like China, Japan, and India.

Merck recently achieved EXCiPACT cGMP certification for Pharmaceutical Auxiliary Materials at its global Cell Culture Media production sites, a significant milestone in the industry. This certification sets a high standard for quality and safety in the production of pharmaceutical materials.

S&S Insider, a leading market research and consulting agency, provides in-depth insights and analysis on the Cell Freezing Media Market. Their comprehensive report covers market dynamics, key developments, competitive landscape, segmentation by product and application, regional analysis, and more. For more information and customization options, contact [email protected].



Read more at GlobeNewswire: Cell Freezing Media Market Size To Worth USD 333.29 Billion